Roche is a leading global healthcare company dedicated to advancing chronic Hepatitis C virus (HCV) management through innovative diagnostic solutions. Their cutting-edge HCV Dual Probe approach employs an optimized, automated extraction and amplification process that enhances the accuracy of HCV RNA detection. This system is adept at distinguishing true signals from background noise, a vital capability for predicting patient responses and personalizing combination therapy.

Roche Molecular Diagnostics offers the quantitative HCV RNA assay, ensuring highly sensitive identification of HCV RNA across various genotypes, even at low viral loads. This precision supports optimized treatment protocols, significantly improving patient outcomes. Roche’s commitment to innovation extends beyond HCV, featuring a diverse portfolio of products and services in areas like infectious diseases, oncology, and anatomic pathology. By fostering collaboration between researchers, diagnostic labs, and clinicians, Roche aims to enhance healthcare delivery and contribute to the global effort to eliminate HCV.